Integrated Filing — IndAS



General information about company
Scrip Code 530549
NSE Symbol SHILPAMED
MSEI Symbol NOTLISTED
ISIN INE790G01031
Name of company SHILPA MEDICARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment PHARMACETICAL
Start date and time of board meeting 26-May-2025   12:48:00
End date and time of board meeting 26-May-2025   16:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 3308049000 12864140000
Other income 75733000 231534000
Total income 3383782000 13095674000
2 Expenses
(a) Cost of materials consumed 851406000 3502739000
(b) Purchases of stock-in-trade 66431000 224845000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 126863000 376123000
(d) Employee benefit expense 709298000 2927092000
(e) Finance costs 144939000 755329000
(f) Depreciation, depletion and amortisation expense 287928000 1129925000
(f) Other Expenses
1 Other expenses 786342000 2662864000
Total other expenses 786342000 2662864000
Total expenses 2973207000 11578917000
3 Total profit before exceptional items and tax 410575000 1516757000
4 Exceptional items -280814000 -280814000
5 Total profit before tax 129761000 1235943000
6 Tax expense
7 Current tax 106367000 733490000
8 Deferred tax -98705000 -293129000
9 Total tax expenses 7662000 440361000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 122099000 795582000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 22992000 -12653000
16 Total profit (loss) for period 145091000 782929000
17 Other comprehensive income net of taxes -23864000 -23008000
18 Total Comprehensive Income for the period 121227000 759921000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0 0
Total profit or loss, attributable to non-controlling interests 21000 -38000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0 0
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0 0
21 Details of equity share capital
Paid-up equity share capital 97791000 97791000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 23624602000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.48 8.04
Diluted earnings (loss) per share from continuing operations 1.48 8.04
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.48 8.04
Diluted earnings (loss) per share from continuing and discontinued operations 1.48 8.04
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 11860351000
Capital work-in-progress 4625216000
Investment property
Goodwill 462308000
Other intangible assets 1855732000
Intangible assets under development 3592467000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 345394000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 62521000
Total non-current financial assets 407915000
Deferred tax assets (net) 129656000
Other non-current assets 316709000
Total non-current assets 23250354000
2 Current assets
Inventories 3479277000
Current financial asset
Current investments 0
Trade receivables, current 4408356000
Cash and cash equivalents 259683000
Bank balance other than cash and cash equivalents 25554000
Loans, current 0
Other current financial assets 300372000
Total current financial assets 4993965000
Current tax assets (net) 47320000
Other current assets 1336163000
Total current assets 9856725000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 33107079000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 97762000
Other equity 23624602000
Total equity attributable to owners of parent 23722364000
Non controlling interest -85348000
Total equity 23637016000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 2319569000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 152759000
Total non-current financial liabilities 2472328000
Provisions, non-current 255413000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 2727741000
Current liabilities
Current financial liabilities
Borrowings, current 3544057000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 82277000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 871538000
Total Trade payable 953815000
Other current financial liabilities 1312741000
Total current financial liabilities 5810613000
Other current liabilities 432584000
Provisions, current 499125000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 6742322000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 9470063000
Total equity and liabilites 33107079000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of the defined benefit (liability)/asset -35803000 -34646000
2 Income tax relating to the above 11939000 11638000
Total Amount of items that will not be reclassified to profit and loss -23864000 -23008000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -23864000 -23008000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1235943000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 755329000
Adjustments for decrease (increase) in inventories -223156000
Adjustments for decrease (increase) in trade receivables, current -554482000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets -449996000
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -694444000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 545327000
Adjustments for depreciation and amortisation expense 1129925000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 10163000
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 545327000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -43068000
Adjustments for dividend income 0
Adjustments for interest income 79582000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -1178000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -216952000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 723213000
Net cash flows from (used in) operations 1959156000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 470272000
Other inflows (outflows) of cash -167098000
Net cash flows from (used in) operating activities 1321786000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 80526000
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 2436340000
Proceeds from sales of investment property 275051000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 80522000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 9392000
Net cash flows from (used in) investing activities -1990849000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 4891034000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -3491709000
Repayments of borrowings 0
Payments of lease liabilities 5524000
Dividends paid 0
Interest paid 767261000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 626540000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -42523000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -42523000
Cash and cash equivalents cash flow statement at beginning of period 0
Cash and cash equivalents cash flow statement at end of period -42523000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 BNPS AND ASSOCIATES LLP Yes 31-May-2028